Skip to main content
. 2017 Mar;23(3):10.18553/jmcp.2017.23.3.327. doi: 10.18553/jmcp.2017.23.3.327

TABLE 2.

Patient Demographics

Variable Continuers (n = 12,224) Interrupters (n = 11,421) Total (N = 23,645) P Valueb
Age,a mean (SD) years 51.8 (9.0) 50.1 (10.2) 51.0 (9.7) < 0.001
Sex, male, n (%, SD) 7,018 (57.4) 6,200 (54.3) 13,218 (55.9) < 0.001
U.S. region, n (%, SD)
 North central 3,480 (28.5) 2,904 (25.4) 6,384 (27.0) < 0.001
 Northeast 1,380 (11.3) 1,211 (10.6) 2,591 (11.0)  
 South 4,857 (39.7) 5,220 (45.7) 10,077 (42.6)  
 West 1,829 (15.0) 1,675 (14.7) 3,504 (14.8)  
 Unknown/missing 678 (5.5) 411 (3.6) 1,089 (4.6)  
Index basal insulin, n (%, SD)
 Insulin detemir 2,946 (24.1) 2,881 (25.2) 5,827 (24.6) 0.045
 Insulin glargine 9,278 (75.9) 8,540 (74.8) 17,818 (75.4)  
Mode of delivery,a n (%, SD)
 Pen 9,045 (74.0) 8,701 (76.2) 17,746 (75.1) 0.001
 Vial 3,165 (25.9) 2,708 (23.7) 5,873 (24.8)  
 Both 14 (0.1) 12 (0.1) 26 (0.1)  

aOn index date.

bContinuers versus interrupters; chi-square test for categorical variables and Wilcoxon test for continuous variables.

SD = standard deviation.